Compare Stocks

Date Range: 

 Alignment HealthcareOscar HealthClover Health InvestmentsTrupanionAdvanzeon Solutions
SymbolNASDAQ:ALHCNYSE:OSCRNASDAQ:CLOVNASDAQ:TRUPOTCMKTS:CHCR
Price Information
Current Price$20.51$15.25$7.92$114.95$0.04
50-Day Moving Average$23.03$21.89$10.66$106.57$0.06
52-Week Low$16.32$15.16$6.31$53.54$0.02
52-Week High$28.59$37.00$28.85$126.53$0.29
MarketRank™
Overall Score2.12.11.42.01.0
Analysis Score3.33.41.91.30.0
Community Score5.05.04.34.74.3
Dividend Score0.00.00.00.00.0
Ownership Score1.71.70.03.30.8
Earnings & Valuation Score0.60.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyN/A
Consensus Price Target$31.00$37.83$9.50$112.50N/A
% Upside from Price Target51.15% upside148.09% upside19.95% upside-2.13% downsideN/A
Trade Information
Market Cap$3.84 billion$3.16 billion$3.23 billion$4.60 billion$5.35 million
BetaN/AN/A11.892.28
Average Volume391,6571,000,07536,209,953367,43423,203
Sales & Book Value
Annual Revenue$959.22 million$462.80 millionN/A$502.03 million$300,000.00
Price / Sales4.006.83N/A9.1717.83
CashflowN/AN/AN/A$0.03 per shareN/A
Price / CashN/AN/AN/A3,297.45N/A
Book ValueN/AN/A$0.20 per share$9.55 per share($0.40) per share
Price / BookN/A12.04-0.11
Profitability
Net Income$-22,930,000.00$-406,830,000.00$-6,740,000.00$-5,840,000.00$-3,260,000.00
EPSN/AN/AN/A($0.16)N/A
Trailing P/E Ratio0.000.000.00N/A0.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-3.15%N/A
Return on Equity (ROE)N/AN/A-17.88%-7.13%N/A
Return on Assets (ROA)N/AN/A-3.19%-4.24%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.41%N/A0.04%N/AN/A
Current Ratio3.56%1.63%4.68%2.07%N/A
Quick Ratio3.56%1.63%4.68%2.07%N/A
Ownership Information
Institutional Ownership Percentage77.53%69.23%38.20%77.35%N/A
Insider Ownership PercentageN/AN/AN/A6.77%16.50%
Miscellaneous
Employees7751,8394589112
Shares Outstanding187.27 million207.38 million408.10 million40.06 million119.91 million
Next Earnings Date8/9/2021 (Confirmed)8/12/2021 (Confirmed)8/11/2021 (Confirmed)8/5/2021 (Confirmed)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
News for Comprehensive Care CorpNews for Comprehensive Care Corp
markets.businessinsider.com - December 24 at 7:55 AM
Insider Buys Advanzeon Solutions StockInsider Buys Advanzeon Solutions Stock
finance.yahoo.com - September 16 at 12:49 AM
Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary Material Streamlining of its Sleep Apnea Screening and Testing Process to Accommodate Increased Patient VolumeAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary Material Streamlining of its Sleep Apnea Screening and Testing Process to Accommodate Increased Patient Volume
finance.yahoo.com - August 17 at 6:06 PM
Advanzeon Solutions, Inc.’s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Announces Medical Director andAdvanzeon Solutions, Inc.’s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Announces Medical Director and
www.bloomberg.com - June 7 at 6:00 PM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiarys SleepMaster Solutions(TM) Sleep Apnea Program Extended by ProminAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary's SleepMaster Solutions(TM) Sleep Apnea Program Extended by Promin
www.bloomberg.com - May 25 at 12:30 AM
Advanzeon Solutions, Inc.s Wholly-Owned Subsidiary Announces Launch of Its SleepMaster Solutions Program with CoreChoiceAdvanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Announces Launch of Its SleepMaster Solutions Program with CoreChoice
finance.yahoo.com - April 29 at 10:51 AM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiary Fast Forwards its Efforts to Help Combat COVID-19Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary Fast Forwards its Efforts to Help Combat COVID-19
finance.yahoo.com - April 13 at 2:21 PM
Advanzeon Solutions, Inc.’s Message from its CEO Regarding the Fight Against COVID-19Advanzeon Solutions, Inc.’s Message from its CEO Regarding the Fight Against COVID-19
apnews.com - April 2 at 2:04 AM
Advanzeon Solutions, Inc.s Message from its CEO Regarding the Fight Against COVID-19Advanzeon Solutions, Inc.'s Message from its CEO Regarding the Fight Against COVID-19
finance.yahoo.com - April 1 at 4:04 PM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiary Announces Exclusive 3-Year Contract with CoreChoiceAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary Announces Exclusive 3-Year Contract with CoreChoice
www.finanznachrichten.de - February 27 at 12:39 AM
Advanzeon Solutions, Inc.’s Wholly Owned Subsidiary Announces Exclusive 3-Year Contract with CoreChoiceAdvanzeon Solutions, Inc.’s Wholly Owned Subsidiary Announces Exclusive 3-Year Contract with CoreChoice
finance.yahoo.com - February 26 at 2:38 PM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Hires New Chief MarketAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Hires New Chief Market
www.bloomberg.com - February 14 at 9:26 PM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Hires New Chief Marketing OfficerAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Hires New Chief Marketing Officer
finance.yahoo.com - December 9 at 12:27 PM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Exclusive 3-Year Contract with Pinnacle NationalAdvanzeon Solutions, Inc.s' Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Exclusive 3-Year Contract with Pinnacle National
finance.yahoo.com - October 16 at 1:10 PM
Advanzeon Solutions IncAdvanzeon Solutions Inc
markets.ft.com - October 12 at 10:53 PM
Advanzeon Solutions, Inc.s Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces New National Manager of Sales and MarketingAdvanzeon Solutions, Inc.'s Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces New National Manager of Sales and Marketing
finance.yahoo.com - September 20 at 4:44 AM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Strategic Relationship with Crank CommunicationsAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Strategic Relationship with Crank Communications
finance.yahoo.com - August 19 at 4:29 PM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiarys SleepMaster Solutions(TM) Sleep Apnea Program Extended by Prominent Teamsters Health and Welfare Trust FundAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary's SleepMaster Solutions(TM) Sleep Apnea Program Extended by Prominent Teamsters Health and Welfare Trust Fund
finance.yahoo.com - July 24 at 4:28 PM
Advanzeon Solutions, Inc.s Wholly Owned Subsidiarys SleepMaster Solutions (TM) Sleep Apnea Program has been Selected by All Aboard America! for its Drivers and EmployeesAdvanzeon Solutions, Inc.'s Wholly Owned Subsidiary's SleepMaster Solutions (TM) Sleep Apnea Program has been Selected by All Aboard America! for its Drivers and Employees
finance.yahoo.com - July 8 at 10:54 AM
Advanzeon Solutions, Inc. Brings Financial Filings CurrentAdvanzeon Solutions, Inc. Brings Financial Filings Current
finance.yahoo.com - June 18 at 9:42 PM
Advanzeon Solutions, Inc. Announces Management and Infrastructure Enhancements and Lease ExtensionAdvanzeon Solutions, Inc. Announces Management and Infrastructure Enhancements and Lease Extension
finance.yahoo.com - May 31 at 4:21 PM
DateCompanyBrokerageAction
7/12/2021Clover Health InvestmentsJPMorgan Chase & Co.
Downgrade
7/2/2021Alignment HealthcareMorgan Stanley
Boost Price Target
6/10/2021Clover Health InvestmentsBank of America
Downgrade
5/24/2021Clover Health InvestmentsBank of America
Reiterated Rating
5/19/2021Clover Health InvestmentsCredit Suisse Group
Lower Price Target
5/18/2021Alignment HealthcareRaymond James
Boost Price Target
5/18/2021Clover Health InvestmentsCitigroup
Lower Price Target
5/17/2021Clover Health InvestmentsBank of America
Downgrade
4/20/2021Alignment HealthcareRaymond James
Initiated Coverage
4/20/2021Alignment HealthcareMorgan Stanley
Initiated Coverage
4/20/2021Alignment HealthcareBank of America
Initiated Coverage
4/20/2021Alignment HealthcareWilliam Blair
Initiated Coverage
4/20/2021Alignment HealthcareUBS Group
Initiated Coverage
4/20/2021Alignment HealthcareThe Goldman Sachs Group
Initiated Coverage
4/20/2021Alignment HealthcarePiper Sandler
Initiated Coverage
4/5/2021TrupanionEvercore ISI
Initiated Coverage
3/29/2021Oscar HealthWells Fargo & Company
Initiated Coverage
3/29/2021Oscar HealthBank of America
Initiated Coverage
3/29/2021Oscar HealthMorgan Stanley
Initiated Coverage
3/29/2021Oscar HealthCowen
Initiated Coverage
3/29/2021Oscar HealthThe Goldman Sachs Group
Initiated Coverage
3/29/2021Oscar HealthCredit Suisse Group
Initiated Coverage
3/9/2021Clover Health InvestmentsCredit Suisse Group
Initiated Coverage
3/3/2021Clover Health InvestmentsCitigroup
Lower Price Target
2/11/2021TrupanionLake Street Capital
Boost Price Target
2/11/2021TrupanionCanaccord Genuity
Boost Price Target
2/2/2021Clover Health InvestmentsCitigroup
Initiated Coverage
2/1/2021Clover Health InvestmentsJPMorgan Chase & Co.
Initiated Coverage
11/2/2020TrupanionCanaccord Genuity
Boost Price Target
10/30/2020TrupanionLake Street Capital
Boost Price Target
8/10/2020TrupanionGuggenheim
Downgrade
8/5/2020TrupanionCanaccord Genuity
Boost Price Target
8/5/2020TrupanionLake Street Capital
Boost Price Target
8/5/2020TrupanionNorthland Securities
Downgrade
7/30/2020TrupanionStifel Nicolaus
Boost Price Target
6/25/2020TrupanionNorthland Securities
Initiated Coverage
6/15/2020TrupanionRoyal Bank of Canada
Reiterated Rating
6/9/2020TrupanionNorthland Securities
Initiated Coverage
5/1/2020TrupanionLake Street Capital
Reiterated Rating
5/1/2020TrupanionRoyal Bank of Canada
Boost Price Target
5/1/2020TrupanionNorthland Securities
Reiterated Rating
4/27/2020TrupanionRoyal Bank of Canada
Reiterated Rating
4/8/2020TrupanionRoyal Bank of Canada
Reiterated Rating
4/6/2020TrupanionNorthland Securities
Reiterated Rating
3/2/2020TrupanionCanaccord Genuity
Reiterated Rating
2/14/2020TrupanionLake Street Capital
Boost Price Target
2/14/2020TrupanionCanaccord Genuity
Reiterated Rating
2/14/2020TrupanionRaymond James
Downgrade
1/8/2020TrupanionStifel Nicolaus
Downgrade
11/18/2019TrupanionGuggenheim
Boost Price Target
2/13/2019Clover Health InvestmentsHC Wainwright
Initiated Coverage
(Data available from 8/4/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.